Madeleine Williams
Stock Analyst at Canaccord Genuity
(2.45)
# 3,092
Out of 4,651 analysts
88
Total ratings
46.5%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by Madeleine Williams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ATH Alterity Therapeutics Limited | Maintained: Buy | $0.95 | $0.55 | +74.31% | 5 | Aug 13, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $8.41 | $2.63 | +219.77% | 12 | Aug 10, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $3.23 → $3.56 | $2.21 | +61.09% | 6 | Aug 6, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $24.00 → $24.76 | $23.45 | +5.59% | 7 | Aug 6, 2026 | |
| ASX: MYX Mayne Pharma Group Limited | Maintained: Buy | $3.83 | $3.20 | +19.69% | 4 | Aug 2, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Maintained: Hold | $0.27 → $0.32 | $0.28 | +14.29% | 3 | Jul 30, 2026 | |
| ASX: BOT Botanix Pharmaceuticals Limited | Maintained: Buy | $0.14 | $0.02 | +536.36% | 6 | Jul 29, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.15 | $0.03 | +476.92% | 9 | Jul 8, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Maintained: Buy | $2.28 | $2.04 | +11.76% | 7 | Jul 4, 2026 | |
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.15 | $2.80 | +12.50% | 5 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.84 | $2.14 | +32.71% | 3 | Jun 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.27 | $0.30 | +669.49% | 11 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180.82 → $168.62 | $178.86 | -5.73% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.27 → $0.40 | $0.05 | +669.23% | 3 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.84 → $27.90 | $9.55 | +192.15% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.33 → $27.41 | $16.73 | +63.84% | 2 | Oct 15, 2025 |
Alterity Therapeutics Limited
Aug 13, 2026
Maintained: Buy
Price Target: $0.95
Current: $0.55
Upside: +74.31%
Clarity Pharmaceuticals Ltd
Aug 10, 2026
Maintained: Buy
Price Target: $8.41
Current: $2.63
Upside: +219.77%
Mesoblast Limited
Aug 6, 2026
Maintained: Buy
Price Target: $3.23 → $3.56
Current: $2.21
Upside: +61.09%
Neuren Pharmaceuticals Limited
Aug 6, 2026
Maintained: Buy
Price Target: $24.00 → $24.76
Current: $23.45
Upside: +5.59%
Mayne Pharma Group Limited
Aug 2, 2026
Maintained: Buy
Price Target: $3.83
Current: $3.20
Upside: +19.69%
Mach7 Technologies Limited
Jul 30, 2026
Maintained: Hold
Price Target: $0.27 → $0.32
Current: $0.28
Upside: +14.29%
Botanix Pharmaceuticals Limited
Jul 29, 2026
Maintained: Buy
Price Target: $0.14
Current: $0.02
Upside: +536.36%
Syntara Limited
Jul 8, 2026
Maintained: Buy
Price Target: $0.15
Current: $0.03
Upside: +476.92%
Imricor Medical Systems, Inc.
Jul 4, 2026
Maintained: Buy
Price Target: $2.28
Current: $2.04
Upside: +11.76%
Cogstate Limited
Jun 11, 2026
Maintained: Buy
Price Target: $3.15
Current: $2.80
Upside: +12.50%
Jun 6, 2026
Maintained: Buy
Price Target: $2.84
Current: $2.14
Upside: +32.71%
May 20, 2026
Maintained: Buy
Price Target: $2.27
Current: $0.30
Upside: +669.49%
May 12, 2026
Maintained: Buy
Price Target: $180.82 → $168.62
Current: $178.86
Upside: -5.73%
Mar 13, 2026
Maintained: Buy
Price Target: $1.27 → $0.40
Current: $0.05
Upside: +669.23%
Mar 2, 2026
Maintained: Buy
Price Target: $32.84 → $27.90
Current: $9.55
Upside: +192.15%
Oct 15, 2025
Maintained: Buy
Price Target: $27.33 → $27.41
Current: $16.73
Upside: +63.84%